After being diagnosed with Alzheimer’s disease or another form of dementia, many people relocate, according to a new report.

Local community members recently came together at Essentia Health Plaza at The Lights for this year’s Walk to End ...

Annovis faces financial challenges and questionable efficacy in Alzheimer's and Parkinson's trials, risking poor stock ...

Potomac-based IGC Pharma Inc. Thursday announced enrollment of patients at the Baycrest Academy for Research and Education in ...

A self-proclaimed Brazil-Italy collaboration enthusiast, researcher Laura Bolognesi created the B2AlzD2 Joint Lab at the ...

Annovis has limited cash reserves and faces challenges in financing further trials, making the future of Buntanetap uncertain ...

Weight-loss drugs such as Ozempic, made by Denmark's Novo Nordisk, can reduce rates of opioid and alcohol abuse by up to 50%, according to a new study that supports expectations the drugs can offer ...

The matter of what causes complicated neurological disorders like Alzheimer’s or multiple sclerosis continues to perplex scientists and doctors, with unknowns impeding early diagnosis and successful ...

TOLEDO, OH, Oct. 17, 2024—1.4 million people nationwide live with Lewy body dementia (LBD) according to the Lewy Body ...

The Italian Hospital Group of Guidonia Montecelio (RM), the RSA San Giuseppe of Rome, and Villa Carla and Villa Silviana of ...

More than 600 people are expected to unite Saturday at Harris Pavilion in Manassas for the Alzheimer’s Association Walk to ...

Dementia can take up to two years to diagnose but a new laser-based technique is cheaper and can provide results in just ...